Interleukin-5 and IL-5 receptor in health and diseases

Department of Immunobiology and Pharmacological Genetics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan.
Proceedings of the Japan Academy Ser B Physical and Biological Sciences (Impact Factor: 2.65). 10/2011; 87(8):463-85. DOI: 10.2183/pjab.87.463
Source: PubMed


While interleukin-5 (IL-5) is initially identified by its ability to support the growth and terminal differentiation of mouse B cells in vitro into antibody-secreting cells, recombinant IL-5 exerts pleiotropic activities on various target cells including B cells, eosinophils, and basophils. IL-5 is produced by both hematopoietic and non-hematopoietic cells including T cells, granulocytes, and natural helper cells. IL-5 exerts its effects for proliferation and differentiation via receptors that comprise an IL-5-specific α and common β-subunit. IL-5Rα expression in activated B cells is regulated by a complex of transcription factors including E12, E47, Sp1, c/EBPβ, and Oct2. IL-5 signals are transduced through JAK-STAT, Btk, and Ras/Raf-ERK signaling pathways and lead to maintenance of survival and functions of B cells and eosinophils. Overexpression of IL-5 in vivo significantly increases eosinophils and B cells in number, while mice lacking a functional gene for IL-5 or IL-5 receptor display a number of developmental and functional impairments in B cells and eosinophil lineages. In humans, the biologic effects of IL-5 are best characterized for eosinophils. The recent expansion in our understanding of eosinophil development and activation and pathogenesis of eosinophil-dependent inflammatory diseases has led to advance in therapeutic options. Intravenous administration of humanized anti-IL-5 monoclonal antibody reduces baseline bronchial mucosal eosinophils in mild asthma; providing important implications for strategies that inhibit the actions of IL-5 to treat asthma and other allergic diseases.

Download full-text


Available from: Kiyoshi Takatsu
  • Source
    • "This may be due to the IFN-β treatment of MS, as it has been demonstrated that this causes increased IL-10 production[58]. The differentiation of naive B cells into antibody secreting plasma cells is profoundly influenced by IL-5, which is produced by Th2 and NK cells[59]. The elevated levels of IL-5 have been previously observed in CFS/ME patients [6][10]. "

    Full-text · Article · Jan 2015 · International Journal of Clinical Medicine
  • Source
    • "In 2011, genetic variants in the vicinity of the IL-5 locus were found to be robustly associated with CAD in a large caseecontrol study including a total of 32,717 cases and 75,465 control subjects [11]. IL-5 was originally defined as a " T-cell-replacing factor " that drives activated B cells for terminal differentiation into antibodysecreting plasma cells in mice [12]. In humans, IL-5 is best characterized as a major maturation and differentiation factor for eosinophils [13]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Genetic variants robustly associated with coronary artery disease were reported in the vicinity of the interleukin (IL)-5 locus, and animal studies suggested a protective role for IL-5 in atherosclerosis. Therefore, we set this work to explore IL-5 as a plasma biomarker for early subclinical atherosclerosis, as determined by measures of baseline severity and change over time of carotid intima-media thickness (cIMT). We used biobank and databases of IMPROVE, a large European prospective cohort study of high-risk individuals (n = 3534) free of clinically overt cardiovascular disease at enrollment, in whom composite and segment-specific measures of cIMT were recorded at baseline and after 15 and 30 months. IL-5 was measured with an immunoassay in plasma samples taken at baseline. IL-5 levels were lower in women than in men, lower in the South than in North of Europe, and showed positive correlations with most established risk factors. IL-5 showed significant inverse relationships with cIMT change over time in the common carotid segment in women, but no significant relationships to baseline cIMT in either men or women. Our results suggest that IL-5 may be part of protective mechanisms operating in early atherosclerosis, at least in women. However, the relationships are weak and whereas IL-5 has been proposed as a potential molecular target to treat allergies, it is difficult to envisage such a scenario in coronary artery disease. Copyright © 2015. Published by Elsevier Ireland Ltd.
    Full-text · Article · Dec 2014 · Atherosclerosis
  • Source
    • "Enhanced expression of Cebpb following CAWS administration suggests that downstream target genes of Cebpb, including IL-4 (see below), may be widely activated. IL-5 exerts pleiotropic effects on various target cells, including B cells, eosinophils, and basophils, and overexpression of IL-5 in vivo significantly increases the number of eosinophils and B cells [26]. Lbp is involved in the acute phase immunologic response to Gram-negative bacterial infections through binding to bacterial lipopolysaccharide (LPS), thereby eliciting immune responses by presenting the LPS to the cell surface pattern recognition receptors CD14 and Tlr4 [27]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Candida albicans water-soluble fraction (CAWS), a mannoprotein-beta-glucan complex obtained from the culture supernatant of C. albicans NBRC1385, causes CAWS-mediated vasculitis (CAWS-vasculitis) in B6 and DBA/2 mice with mild and lethal symptoms, respectively. Why CAWS is lethal only in DBA/2 mice remains unknown. We performed DNA microarray analyses using mRNA obtained from peripheral blood mononuclear cells (PBMCs) of B6 and DBA/2 mice and compared their respective transcriptomes. We found that the mRNA levels of interferon-gamma (Ifng) and several genes that regulate the complement system, such as C3, C4, Cfb, Cfh, and Fcna, were increased dramatically only in DBA/2 mice at 4 and 8 weeks after CAWS administration. The dramatic increase was confirmed by quantitative real-time polymerase chain reactions (qRT-PCR). Moreover, mRNA levels of immune-related genes, such as Irf1, Irf7, Irf9, Cebpb, Ccl4, Itgam, Icam1, and IL-12rb1, whose expression levels are known to be increased by Ifng, were also increased, but only in DBA/2 mice. By contrast, the mRNA level of Dectin-2, the critical receptor for the alpha-mannans of CAWS, was increased slightly and similarly in both B6 and DBA/2 mice after CAWS administration. Taken together, our results suggest that CAWS administration induces Dectin-2 mediated CAWS-vasculitis in both B6 and DBA/2 mice and the expression of Ifng, but only in DBA/2 mice, which led to increased expression of C3, C4, Cfb, Cfh, and Fcna and an associated increase in lethality in these mice. This model may contribute to our understanding of the pathogenesis of severe human vasculitis.
    Full-text · Article · Sep 2013 · BMC Immunology
Show more